- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
2Pi Optics has launched a new type of fisheye camera based on its so-called metasurface optics.The company plans to showcase this technology at the large-scale technology trade show CES 2024 in Las Vegas next week.This company, headquartered in Cambridge, Massachusetts, stated that it has created the world's leading high-resolution fisheye sensor based on optical superlens technology. This technol...
A research team in Japan has designed a flexible and shapable X-ray reflector, achieving significant accuracy and higher stability at the atomic level.This new technology, developed by Satoshi Matsuyama and Takato Inoue from the Graduate School of Engineering at Nagoya University, in collaboration with the Japanese Institute of Physical and Chemical Research and JTEC Corporation, improves the perf...
TYVOK, industry leaders in laser engraving technology, just announced the launch of TYVOK K1, a modular CO₂ laser engraver engineered to give makers, designers, schools, and small businesses industrial power with intuitive design and user-friendly operation. TYVOK K1 blends a true 100W optical CO₂ laser engine with precision motion control, a rigid, level platform, and professional-grade safety sy...
At Gulfood Manufacturing 2025 held in Hall 3 of Dubai World Trade Center, Sidel showcased its EvoBLOW laser PET preform laser heating technology for the first time in the Middle East and Africa region.The system, shown earlier this year at drinktec, replaces traditional halogen ovens with precise laser sources. According to the company, the solution enables the production of lighter bottles while ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...